[HTML][HTML] The role of gut microbiota biomodulators on mucosal immunity and intestinal inflammation

C Amoroso, F Perillo, F Strati, M Fantini, F Caprioli… - Cells, 2020 - mdpi.com
Alterations of the gut microbiota may cause dysregulated mucosal immune responses
leading to the onset of inflammatory bowel diseases (IBD) in genetically susceptible hosts …

Differential diagnosis of inflammatory bowel disease: imitations and complications

KB Gecse, S Vermeire - The lancet Gastroenterology & hepatology, 2018 - thelancet.com
Inflammatory bowel disease (IBD) is characterised by episodes of relapse and periods of
remission. However, the clinical features, such as abdominal pain, diarrhoea, and rectal …

ECCO guidelines on therapeutics in Crohn's disease: medical treatment

J Torres, S Bonovas, G Doherty… - Journal of Crohn's …, 2020 - academic.oup.com
2. Methods Based on the GRADE workflow, the Guidelines Committee of ECCO [GuiCom]
selected a panel of 48 experts supported by a team of methodologists and librarians …

ECCO guidelines on therapeutics in Crohn's disease: surgical treatment

M Adamina, S Bonovas, T Raine… - Journal of Crohn's …, 2020 - academic.oup.com
This article is the second in a series of two publications relating to the European Crohn's and
Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn's …

Classifying perianal fistulising Crohn's disease: an expert consensus to guide decision-making in daily practice and clinical trials

J Geldof, N Iqbal, JF LeBlanc… - The Lancet …, 2022 - thelancet.com
Perianal fistulising Crohn's disease is an aggressive disease phenotype that can have a
substantial detrimental impact on patients' quality of life. Current biological understanding of …

[HTML][HTML] Efficacy of stem cells therapy for Crohn's fistula: a meta-analysis and systematic review

Y Cao, Q Su, B Zhang, F Shen, S Li - Stem cell research & therapy, 2021 - Springer
Background Fistulas have puzzled us all the time and stem cell therapy for it is still in its
infancy. We conducted a meta-analysis and systematic review to evaluate the efficacy of …

Efficacy of injection of freshly collected autologous adipose tissue into perianal fistulas in patients with Crohn's disease

A Dige, HT Hougaard, J Agnholt, BG Pedersen… - Gastroenterology, 2019 - Elsevier
Background & Aims Perianal fistulas are common in patients with Crohn's disease (CD).
Injections of cultured autologous and allogeneic adipose tissue-derived stem cells have …

Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of …

Z Ran, K Wu, K Matsuoka, YT Jeen… - Journal of …, 2021 - Wiley Online Library
Inflammatory bowel disease (IBD) has increased in incidence and prevalence in Asian
countries since the end of the 20th century. Moreover, differences in the cause, phenotypes …

Evaluating the safety and efficacy of mesenchymal stem cell-derived exosomes for treatment of refractory perianal fistula in IBD patients: clinical trial phase I

H Nazari, F Alborzi, A Heirani-Tabasi… - Gastroenterology …, 2022 - academic.oup.com
Background Exosome administration is a novel medical approach that promises excellent
immunomodulatory properties without the conventional side effects of current antitumor …

[HTML][HTML] Mesenchymal stem cells transplantation for perianal fistulas: a systematic review and meta-analysis of clinical trials

H Wang, HY Jiang, YX Zhang, HY Jin, BY Fei… - Stem Cell Research & …, 2023 - Springer
Background Perianal fistulas, characterised as granulomatous inflammation of fistulas
around the anal canal, are associated with significant morbidity resulting in a negative …